{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T21:35:32Z","timestamp":1769636132699,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T00:00:00Z","timestamp":1526342400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Youth Foundation of Guangzhou Medical University","award":["2016A24"],"award-info":[{"award-number":["2016A24"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40644-018-0152-x","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T04:05:05Z","timestamp":1526357105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The role of initial 18F-FDG PET\/CT in the management of patients with suspected extramedullary plasmocytoma"],"prefix":"10.1186","volume":"18","author":[{"given":"Linqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rusen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,15]]},"reference":[{"key":"152_CR1","doi-asserted-by":"publisher","first-page":"895765","DOI":"10.1100\/2012\/895765","volume":"2012","author":"S Kilciksiz","year":"2012","unstructured":"Kilciksiz S, Karakoyun-Celik O, Agaoglu FY, Haydaroglu A. A review for solitary plasmacytoma of bone and extramedullary plasmacytoma. ScientificWorldJournal. 2012;2012:895765.","journal-title":"ScientificWorldJournal"},{"issue":"6","key":"152_CR2","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/COC.0b013e31819cca18","volume":"32","author":"R Dagan","year":"2009","unstructured":"Dagan R, Morris CG, Kirwan J, Mendenhall WM. Solitary plasmacytoma. Am J Clin Oncol. 2009;32(6):612\u20137.","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"152_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40880-016-0140-0","volume":"35","author":"Y Leng","year":"2016","unstructured":"Leng Y, Qiu L, Hou J, Zhao Y, Zhang X, Yang S, Xi H, Huang Z, Pan L, Chen W. Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma. Chin J Cancer. 2016;35(1):86.","journal-title":"Chin J Cancer"},{"issue":"2","key":"152_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/alr.21254","volume":"4","author":"C D'Aguillo","year":"2014","unstructured":"D'Aguillo C, Soni RS, Gordhan C, Liu JK, Baredes S, Eloy JA. Sinonasal extramedullary plasmacytoma: a systematic review of 175 patients. Int Forum Allergy Rhinol. 2014;4(2):156\u201363.","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"152_CR5","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/bjh.13870","volume":"172","author":"P Finsinger","year":"2016","unstructured":"Finsinger P, Grammatico S, Chisini M, Piciocchi A, Foa R, Petrucci MT. Clinical features and prognostic factors in solitary plasmacytoma. Br J Haematol. 2016;172(4):554\u201360.","journal-title":"Br J Haematol"},{"issue":"1","key":"152_CR6","first-page":"47","volume":"85","author":"P Galieni","year":"2000","unstructured":"Galieni P, Cavo M, Pulsoni A, Avvisati G, Bigazzi C, Neri S, Caliceti U, Benni M, Ronconi S, Lauria F. Clinical outcome of extramedullary plasmacytoma. Haematologica. 2000;85(1):47\u201351.","journal-title":"Haematologica"},{"issue":"1","key":"152_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1186\/s12885-016-2824-x","volume":"16","author":"Q Zhu","year":"2016","unstructured":"Zhu Q, Zou X, You R, Jiang R, Zhang MX, Liu YP, Qian CN, Mai HQ, Hong MH, Guo L, et al. Establishment of an innovative staging system for extramedullary plasmacytoma. BMC Cancer. 2016;16(1):777.","journal-title":"BMC Cancer"},{"issue":"3","key":"152_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.5312\/wjo.v5.i3.272","volume":"5","author":"T Derlin","year":"2014","unstructured":"Derlin T, Bannas P. Imaging of multiple myeloma: current concepts. World J Orthop. 2014;5(3):272\u201382.","journal-title":"World J Orthop"},{"key":"152_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.critrevonc.2016.03.006","volume":"101","author":"G Rubini","year":"2016","unstructured":"Rubini G, Niccoli-Asabella A, Ferrari C, Racanelli V, Maggialetti N, Dammacco F. Myeloma bone and extra-medullary disease: role of PET\/CT and other whole-body imaging techniques. Crit Rev Oncol Hematol. 2016;101:169\u201383.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"152_CR10","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/00003072-200011000-00003","volume":"25","author":"T Kato","year":"2000","unstructured":"Kato T, Tsukamoto E, Nishioka T, Yamazaki A, Shirato H, Kobayashi S, Asaka M, Imamura M, Tamaki N. Early detection of bone marrow involvement in extramedullary plasmacytoma by whole-body F-18 FDG positron emission tomography. Clin Nucl Med. 2000;25(11):870\u20133.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"152_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/RLU.0000000000001030","volume":"41","author":"L Zhang","year":"2016","unstructured":"Zhang L, Zhang X, Zhang R, Fan W. 18F-FDG PET\/CT metabolic activity in a patient with solitary extramedullary Plasmacytoma of the lung. Clin Nucl Med. 2016;41(3):232\u20134.","journal-title":"Clin Nucl Med"},{"key":"152_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/2156-7514.191127","volume":"6","author":"AA Fakhri","year":"2016","unstructured":"Fakhri AA, Rodrigue PD, Fakhri AF. Extramedullary Plasmacytoma of the gallbladder detected on fluorine 18-fluorodeoxyglucose positron emission tomography\/computed tomography. J Clin Imaging Sci. 2016;6:40.","journal-title":"J Clin Imaging Sci"},{"issue":"6","key":"152_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/RLU.0b013e3182a75c95","volume":"39","author":"YZ Alabed","year":"2014","unstructured":"Alabed YZ, Rakheja R, Laufer J. Solitary extramedullary plasmacytoma of the parotid gland imaged with 18F-FDG PET\/CT. Clin Nucl Med. 2014;39(6):549\u201350.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"152_CR14","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ijrobp.2008.08.037","volume":"74","author":"PJ Kim","year":"2009","unstructured":"Kim PJ, Hicks RJ, Wirth A, Ryan G, Seymour JF, Prince HM, Mac Manus MP. Impact of 18F-fluorodeoxyglucose positron emission tomography before and after definitive radiation therapy in patients with apparently solitary plasmacytoma. Int J Radiat Oncol Biol Phys. 2009;74(3):740\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"152_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1089\/108497803770418382","volume":"18","author":"H Schirrmeister","year":"2003","unstructured":"Schirrmeister H, Buck AK, Bergmann L, Reske SN, Bommer M. Positron emission tomography (PET) for staging of solitary plasmacytoma. Cancer Biother Radiopharm. 2003;18(5):841\u20135.","journal-title":"Cancer Biother Radiopharm"},{"issue":"8","key":"152_CR16","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.3324\/haematol.12654","volume":"93","author":"PY Salaun","year":"2008","unstructured":"Salaun PY, Gastinne T, Frampas E, Bodet-Milin C, Moreau P, Bodere-Kraeber F. FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma. Haematologica. 2008;93(8):1269\u201371.","journal-title":"Haematologica"},{"issue":"1","key":"152_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00259-017-3810-5","volume":"45","author":"D Albano","year":"2018","unstructured":"Albano D, Bosio G, Treglia G, Giubbini R, Bertagna F. 18F-FDG PET\/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma. Eur J Nucl Med Mol Imaging. 2018;45(1):77\u201384.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"152_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/00005792-197605000-00002","volume":"55","author":"E Wiltshaw","year":"1976","unstructured":"Wiltshaw E. The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine (Baltimore). 1976;55(3):217\u201338.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"152_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12885-016-3015-5","volume":"17","author":"N Thumallapally","year":"2017","unstructured":"Thumallapally N, Meshref A, Mousa M, Terjanian T. Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA. BMC Cancer. 2017;17(1):13.","journal-title":"BMC Cancer"},{"issue":"9","key":"152_CR20","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00277-011-1190-7","volume":"90","author":"S Krause","year":"2011","unstructured":"Krause S, Hillengass J, Goldschmidt H, Debus J, Neuhof D. Radiotherapy of solitary plasmacytoma. Ann Hematol. 2011;90(9):1093\u20137.","journal-title":"Ann Hematol"},{"issue":"4","key":"152_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/bjh.14291","volume":"175","author":"EG de Waal","year":"2016","unstructured":"de Waal EG, Leene M, Veeger N, Vos HJ, Ong F, Smit WG, Hovenga S, Hoogendoorn M, Hogenes M, Beijert M, et al. Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands. Br J Haematol. 2016;175(4):661\u20137.","journal-title":"Br J Haematol"},{"issue":"1","key":"152_CR22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s40880-017-0265-9","volume":"36","author":"H Peng","year":"2017","unstructured":"Peng H, Chen L, Tang LL, Li WF, Mao YP, Guo R, Zhang Y, Liu LZ, Tian L, Zhang X, et al. Significant value of (18)F-FDG-PET\/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy. Chin J Cancer. 2017;36(1):95.","journal-title":"Chin J Cancer"},{"issue":"4","key":"152_CR23","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.ijrobp.2005.09.019","volume":"64","author":"L Tournier-Rangeard","year":"2006","unstructured":"Tournier-Rangeard L, Lapeyre M, Graff-Caillaud P, Mege A, Dolivet G, Toussaint B, Charra-Brunaud C, Hoffstetter S, Marchal C, Peiffert D. Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: a dose greater than 45 Gy to the target volume improves the local control. Int J Radiat Oncol Biol Phys. 2006;64(4):1013\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"152_CR24","doi-asserted-by":"crossref","unstructured":"Weber DM. Solitary bone and extramedullary plasmacytoma. Hematology Am Soc Hematol Educ Program. 2005:373\u201376.","DOI":"10.1182\/asheducation-2005.1.373"},{"issue":"8","key":"152_CR25","doi-asserted-by":"publisher","first-page":"e399","DOI":"10.1097\/RLU.0000000000000819","volume":"40","author":"P Alongi","year":"2015","unstructured":"Alongi P, Zanoni L, Incerti E, Fallanca F, Mapelli P, Papathanasiou N, Gianolli L, Picchio M, Bomanji J. 18F-FDG PET\/CT for early Postradiotherapy assessment in solitary bone Plasmacytomas. Clin Nucl Med. 2015;40(8):e399\u2013404.","journal-title":"Clin Nucl Med"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-018-0152-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40644-018-0152-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-018-0152-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T19:15:47Z","timestamp":1557861347000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-018-0152-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,15]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["152"],"URL":"https:\/\/doi.org\/10.1186\/s40644-018-0152-x","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,15]]},"assertion":[{"value":"4 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The current study was approved by the Institutional Ethics Committee of the Affiliated Cancer Hospital&Institute of Guangzhou Medical University (No. 2014111), and the need for signed informed consent was waived.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"19"}}